Merck-Moderna vaccine cuts odds of skin cancer recurrence in half, study finds
CBSN
A vaccine shows promising results in treating the most deadly form of skin cancer, Moderna and Merck announced on Thursday.
Those with severe melanomas who received the vaccine and Merck's cancer drug Keytruda were 49% less likely to die or have their cancer come back after three years than those who were given only Keytruda, the biotech companies said in a news release.
The companies have begun Phase 3 trials of mRNA-4157 with Keytruda, given a breakthrough therapy designation by the Food and Drug Administration earlier this year. The designation is meant to expedite the development and review of drugs meant to treat life-threatening diseases.
Two Native Hawaiian brothers who were convicted in the 1991 killing of a woman visiting Hawaii allege in a federal lawsuit that local police framed them "under immense pressure to solve the high-profile murder" then botched an investigation last year that would have revealed the real killer using advancements in DNA technology.
In one of his first acts after returning to the Oval Office this week, President Trump tasked federal agencies with developing ways to potentially ease prices for U.S. consumers. But experts warn that his administration's crackdown on immigration could both drive up inflation as well as hurt a range of businesses by shrinking the nation's workforce.
Meta is denying claims circulating on social media that it forced Facebook and Instagram users to follow President Trump's official accounts, saying the changes some users noticed were standard practices tied to the transition of the POTUS account from the previous administration to the incoming one.